SectorPharmaceutical
Established Date06/12/2018
Listing Date21/06/2019
ExchangeNASDAQ Stock Exchange
Full-time Employees362
Fiscal Year Ends31/03
Security TypeCommon stock
Office address1000 Park Forty Plaza, Suite 210, Durham, NC 27713
Business
IntroductionImmunovant, Inc., incorporated in Delaware on December 6, 2018, is a clinical-stage biopharmaceutical company focused on providing a normal life for patients with autoimmune diseases.
